7TQ Stock Overview
Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Upexi, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.45 |
| 52 Week High | US$4.04 |
| 52 Week Low | US$0.43 |
| Beta | 0.50 |
| 1 Month Change | -1.74% |
| 3 Month Change | -50.60% |
| 1 Year Change | -88.59% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -91.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7TQ | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -10.5% | -0.2% | -0.8% |
| 1Y | -88.6% | -5.2% | 1.0% |
Return vs Industry: 7TQ underperformed the German Personal Products industry which returned -5.2% over the past year.
Return vs Market: 7TQ underperformed the German Market which returned 1% over the past year.
Price Volatility
| 7TQ volatility | |
|---|---|
| 7TQ Average Weekly Movement | 16.1% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7TQ's share price has been volatile over the past 3 months.
Volatility Over Time: 7TQ's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 95 | Allan Marshall | www.upexi.com |
Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Upexi, Inc. Fundamentals Summary
| 7TQ fundamental statistics | |
|---|---|
| Market cap | €9.64m |
| Earnings (TTM) | -€18.66m |
| Revenue (TTM) | €86.12m |
0.1x
P/S Ratio-0.5x
P/E RatioIs 7TQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7TQ income statement (TTM) | |
|---|---|
| Revenue | US$91.89m |
| Cost of Revenue | US$57.26m |
| Gross Profit | US$34.63m |
| Other Expenses | US$54.55m |
| Earnings | -US$19.91m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.95 |
| Gross Margin | 37.69% |
| Net Profit Margin | -21.67% |
| Debt/Equity Ratio | 110.5% |
How did 7TQ perform over the long term?
See historical performance and comparison